comparemela.com
Home
Live Updates
Laekna Therapeutic - Breaking News
Pages:
Latest Breaking News On - Laekna therapeutic - Page 1 : comparemela.com
Laekna Therapeutics and Innovent Biologics obtain IND approval for combination therapy in patients with specific types of solid tumors who have been refractory to treatment with PD-1/PD-L1 inhibitors
/PRNewswire/ Today, Laekna Therapeutics announced that the investigational new drug (IND) application of a combination therapy for the phase 1/2 clinical.
Shen lin
Chris lu
Yue yong
Eli lilly
University hospital
National reimbursement drug list
Department of gastrointestinal oncology
National medical products administration
Cancer institute
Laekna therapeutics
Drug evaluation
Principal investigator
Professor shen lin
Vice president
Peking university hospital
Laekna therapeutic
vimarsana © 2020. All Rights Reserved.